ARTG Entry
ZIAGEN
ARTG entry for ZIAGEN (abacavir), ARTG 66879 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: ViiV Healthcare
- Active ingredient: abacavir
- Therapeutic area: Infectious Disease
What it is
ZIAGEN is abacavir sulfate, available as a 300 mg tablet or a 20 mg/mL oral solution.
PBS listing
ZIAGEN tablets (300 mg) are listed on the PBS with streamlined restrictions at an ex-manufacturer price of A$178.16. The oral solution (20 mg/mL, 240 mL) is listed on the PBS with authority required restrictions at an ex-manufacturer price of A$66.72.
Regulatory history
ZIAGEN was first registered on the ARTG on 9 June 1999, with both the 300 mg tablet and 20 mg/mL oral solution formulations listed simultaneously.